Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
SpringWorks Therapeutics, Inc. Banner

SpringWorks Therapeutics, Inc.

SWTX Stock Analysis

Page title

Section title

About SpringWorks Therapeutics, Inc.

Biotechnology
Healthcare

SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors...

SpringWorks Therapeutics, Inc. Key Metrics

Market Cap
$3B
52 Weeks Low
$18
52 Weeks High
$53.92
P/B
4.83x
P/E
-8.92x
P/S
29.34x

Upcoming Events

    SWTX Analyst Forecasts

    ‌
    ‌

    SWTX Financials

    SWTX Income Statement Key Metrics

    • Revenue(TTM)91.77 M
    • Gross Profit(TTM)84.65 M
    • EBITDA(TTM)-318.71 M
    • Net Income(TTM)-301.06 M
    • EPS Diluted(TTM)-4.27

    Decode SWTX's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    SWTX earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of SWTX (0.923) is higher than the average of its peers (0.414).

    Net Profit Margin vs Peers

    Net profit margin ratio of SWTX (-59.685) is lower than the average of its peers (-12.318).

    SWTX Return on Equity

    See how efficiently SWTX generates profit for it's shareholders.

    -51.92%

    10
    0
    100

    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of SWTX (-0.519) is higher than the average of its peers (-0.845).

    Return on Equity Growth

    SWTX's Return on Equity has grown significantly over the past 10 years, increasing by over 16.05%.

    SWTX Revenue Growth

    See how SWTX has grown it's revenue over the past 10 years.

    ‌

    Revenue Growth

    SWTX's revenue has grown significantly over the past 10 years, increasing by over 0%.